339 related articles for article (PubMed ID: 19089358)
21. Human ES and iPS cells as cell sources for the treatment of Parkinson's disease: current state and problems.
Hwang DY; Kim DS; Kim DW
J Cell Biochem; 2010 Feb; 109(2):292-301. PubMed ID: 20014069
[TBL] [Abstract][Full Text] [Related]
22. Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease.
Murrell W; Wetzig A; Donnellan M; Féron F; Burne T; Meedeniya A; Kesby J; Bianco J; Perry C; Silburn P; Mackay-Sim A
Stem Cells; 2008 Aug; 26(8):2183-92. PubMed ID: 18535154
[TBL] [Abstract][Full Text] [Related]
23. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.
Shin JY; Park HJ; Ahn YH; Lee PH
J Neurochem; 2009 Nov; 111(4):1042-50. PubMed ID: 19765187
[TBL] [Abstract][Full Text] [Related]
24. [Human pluripotent stem cell and neural differentiation].
Wataya T; Muguruma K; Sasai Y
Brain Nerve; 2008 Oct; 60(10):1165-72. PubMed ID: 18975604
[TBL] [Abstract][Full Text] [Related]
25. Autologous neural stem cell transplantation: a new treatment option for Parkinson's disease?
Arias-Carrión O; Yuan TF
Med Hypotheses; 2009 Nov; 73(5):757-9. PubMed ID: 19467573
[TBL] [Abstract][Full Text] [Related]
26. Stem cells may reshape the prospect of Parkinson's disease therapy.
Sonntag KC; Simantov R; Isacson O
Brain Res Mol Brain Res; 2005 Mar; 134(1):34-51. PubMed ID: 15790528
[TBL] [Abstract][Full Text] [Related]
27. Adjunctive use of the non-ionic surfactant Poloxamer 188 improves fetal dopaminergic cell survival and reinnervation in a neural transplantation strategy for Parkinson's disease.
Quinn M; Mukhida K; Sadi D; Hong M; Mendez I
Eur J Neurosci; 2008 Jan; 27(1):43-52. PubMed ID: 18093176
[TBL] [Abstract][Full Text] [Related]
28. Induction dopamine releasing cells from mouse embryonic stem cells and their long-term culture.
Moriyasu K; Yamazoe H; Iwata H
J Biomed Mater Res A; 2006 Apr; 77(1):136-47. PubMed ID: 16392122
[TBL] [Abstract][Full Text] [Related]
29. From bench to bed: the potential of stem cells for the treatment of Parkinson's disease.
Morizane A; Li JY; Brundin P
Cell Tissue Res; 2008 Jan; 331(1):323-36. PubMed ID: 18034267
[TBL] [Abstract][Full Text] [Related]
30. Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease.
Levy YS; Bahat-Stroomza M; Barzilay R; Burshtein A; Bulvik S; Barhum Y; Panet H; Melamed E; Offen D
Cytotherapy; 2008; 10(4):340-52. PubMed ID: 18574767
[TBL] [Abstract][Full Text] [Related]
31. [Stem cells: solution to the problem of transplants in Parkinson's disease?].
Linazasoro G
Neurologia; 2003 Mar; 18(2):74-100. PubMed ID: 12610757
[TBL] [Abstract][Full Text] [Related]
32. Translation of stem cell therapy for neurological diseases.
Schwarz SC; Schwarz J
Transl Res; 2010 Sep; 156(3):155-60. PubMed ID: 20801412
[TBL] [Abstract][Full Text] [Related]
33. [Cell therapy in Parkinson's disease].
Shingo T
Rinsho Shinkeigaku; 2004 Nov; 44(11):951-3. PubMed ID: 15651341
[TBL] [Abstract][Full Text] [Related]
34. Current state of stem cell research for the treatment of Parkinson's disease.
Gerlach M; Braak H; Hartmann A; Jost WH; Odin P; Priller J; Schwarz J
J Neurol; 2002 Oct; 249 Suppl 3():III/33-5. PubMed ID: 12522570
[TBL] [Abstract][Full Text] [Related]
35. Cripto as a target for improving embryonic stem cell-based therapy in Parkinson's disease.
Parish CL; Parisi S; Persico MG; Arenas E; Minchiotti G
Stem Cells; 2005 Apr; 23(4):471-6. PubMed ID: 15790767
[TBL] [Abstract][Full Text] [Related]
36. [Bone marrow stromal cell-mediated enhancement in the survival of dopamine cells and neuronal differentiation from ES cells].
Shintani A; Nakao N; Kakishita K; Itakura T
No Shinkei Geka; 2007 Jun; 35(6):607-14. PubMed ID: 17564054
[No Abstract] [Full Text] [Related]
37. Stem cell therapy for Parkinson's disease.
Takahashi J
Expert Rev Neurother; 2007 Jun; 7(6):667-75. PubMed ID: 17563250
[TBL] [Abstract][Full Text] [Related]
38. Cell therapy for Parkinson's disease: problems and prospects.
Björklund A
Novartis Found Symp; 2005; 265():174-86; discussion 187, 204-211. PubMed ID: 16050257
[TBL] [Abstract][Full Text] [Related]
39. One year survival and significant reversal of motor deficits in parkinsonian rats transplanted with hESC derived dopaminergic neurons.
Geeta R; Ramnath RL; Rao HS; Chandra V
Biochem Biophys Res Commun; 2008 Aug; 373(2):258-64. PubMed ID: 18565328
[TBL] [Abstract][Full Text] [Related]
40. Pattern of long-term sensorimotor recovery following intrastriatal and--accumbens DA micrografts in a rat model of Parkinson's disease.
Falkenstein G; Rosenthal C; Reum T; Morgenstern R; Döbrössy M; Nikkhah G
J Comp Neurol; 2009 Jul; 515(1):41-55. PubMed ID: 19399892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
